Budget Amount *help |
¥14,300,000 (Direct Cost: ¥11,000,000、Indirect Cost: ¥3,300,000)
Fiscal Year 2020: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2019: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2018: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
|
Outline of Final Research Achievements |
Tools for high-throughput structure modeling (Repertoire Builder), clustering (InterClone), TCR-peptide-MHC complex modeling (ImmuneScape) have been developed. These tools are at least as accurate as low-throughput tools, and for Repertoire Builder and InterClone are the only tools in their class. We applied these tools to understand the structural basis of antibodies and TCRs in several diseases, including COVID-19. We experimentally validated identified TCRs-peptide-MHC complexes from SARS-CoV-2.
|